Some believe that there are only four Rolling Stones, but then some say there's a fifth: keyboardist Chuck Leavell. He's been on tours with the band for more than 30 years — but that hasn't been his only gig. At 20, he was asked to join The Allman Brothers Band.
When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics.
So its maker, Forest Laboratories, launched a promotional assault on the group in the best position to determine Bystolic's success: those in control of prescription pads. It flooded the offices of health professionals with drug reps, and it hired doctors to persuade their peers to choose Bystolic — even though the drug hadn't proved more effective than competitors.
This is MORNING EDITION from NPR News. I'm David Greene.
RENEE MONTAGNE, HOST:
And I'm Renee Montagne. The U.S. Supreme Court sent back to an appeals court, a high-profile affirmative action case this morning. In a seven to one decision, the country's highest court effectively told the lower court to go back and do it right. For more, we have NPR's legal affairs correspondent Nina Totenberg at the Supreme Court. And, Nina, what exactly did the court say?